Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France (Q47226642)
Jump to navigation
Jump to search
scientific article published on 5 October 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France |
scientific article published on 5 October 2017 |
Statements
1 reference
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France (English)
1 reference
Jérôme Avouac
1 reference
Maxime Dougados
1 reference
Anna Moltó
1 reference
Vered Abitbol
1 reference
Adrien Etcheto
1 reference
Axelle Salcion
1 reference
Loriane Gutermann
1 reference
Caroline Klotz
1 reference
Muriel Elhai
1 reference
Pascal Cohen
1 reference
Pierre Antoine Soret
1 reference
Florence Morin
1 reference
Ornella Conort
1 reference
François Chast
1 reference
Claire Goulvestre
1 reference
Claire Le Jeunne
1 reference
Stanislas Chaussade
1 reference
André Kahan
1 reference
Christian Roux
1 reference
Yannick Allanore
1 reference
5 October 2017
1 reference